Doxorubicin

Title	Average Rating
Hyperthermia adds to chemotherapy.	90.00%
Bone-targeted therapy for advanced androgen-independent carcinoma of the prostate: a randomised phase II trial.	80.00%
Dose-Dense and/or Metronomic Schedules of Specific Chemotherapies Consolidate the Chemosensitivity of Triple-Negative Breast Can	63.33%
SWOG 0012, a randomized phase III comparison of standard doxorubicin (A) and cyclophosphamide (C) followed by weekly paclitaxel	60.00%
Clinical management of adrenocortical carcinoma	60.00%
A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin....	50.00%

Languages